897
Views
21
CrossRef citations to date
0
Altmetric
Commentary & View

The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme

A biological perspective

, &
Pages 51-56 | Received 03 Jul 2008, Accepted 31 Jul 2008, Published online: 01 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Grazia R. Tundo, Diego Sbardella, Chiara Ciaccio, Giuseppe Grasso, Magda Gioia, Andrea Coletta, Fabio Polticelli, Donato Di Pierro, Danilo Milardi, Peter Van Endert, Stefano Marini & Massimo Coletta. (2017) Multiple functions of insulin-degrading enzyme: a metabolic crosslight?. Critical Reviews in Biochemistry and Molecular Biology 52:5, pages 554-582.
Read now
J Lasierra-Cirujeda, P Coronel, MJ Aza & M Gimeno. (2013) Beta-amyloidolysis and glutathione in Alzheimer’s disease. Journal of Blood Medicine 4, pages 31-38.
Read now

Articles from other publishers (19)

Shobha Kumari, Jayant Singh Bhardwaj, Sanskruti Santosh Kharavtekar, Deepika Grewal, Shreyasi Ghosh Ray, Abhay Bhardwaj, Sunil Kumar Dubey, Prashant Kesharwani, Taruna Arora & Rajeev Taliyan. 2023. Nanomedicine-Based Approaches for the Treatment of Dementia. Nanomedicine-Based Approaches for the Treatment of Dementia 265 294 .
Karina Abramov-Harpaz & Yifat Miller. (2022) Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme. Biomolecules 12:12, pages 1886.
Crossref
Laetitia Lesire, Florence Leroux, Rebecca Deprez-Poulain & Benoit Deprez. (2022) Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?. Cells 11:7, pages 1228.
Crossref
Luís Sousa, Mariana Guarda, Maria João Meneses, M Paula Macedo & Hugo Vicente Miranda. (2021) Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases. The Journal of Pathology 255:4, pages 346-361.
Crossref
Bhargavi Ramaraju, Spencer L. Nelson, Wenwei Zheng, Rodolfo Ghirlando & Lalit Deshmukh. (2021) Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity. Biochemistry 60:33, pages 2519-2523.
Crossref
Hans-Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny & Johann Steiner. (2019) Binding varicella zoster virus: an underestimated facet of insulin-degrading enzyme´s implication for Alzheimer´s disease pathology?. European Archives of Psychiatry and Clinical Neuroscience 270:4, pages 495-496.
Crossref
Igor V. Kurochkin, Enrico Guarnera & Igor N. Berezovsky. (2018) Insulin-Degrading Enzyme in the Fight against Alzheimer’s Disease. Trends in Pharmacological Sciences 39:1, pages 49-58.
Crossref
Komal Panchal, Ajay Kumar & Anand K. Tiwari. 2018. HSP70 in Human Diseases and Disorders. HSP70 in Human Diseases and Disorders 3 35 .
Melissa A. Schilling. (2016) Unraveling Alzheimer’s: Making Sense of the Relationship between Diabetes and Alzheimer’s Disease1. Journal of Alzheimer's Disease 51:4, pages 961-977.
Crossref
Joaquín Lasierra-Cirujeda, María José Aza Pascual-Salcedo & María Mercedes Aza Pascual-Salcedo. (2016) Sulodexide and Alzheimer’s Disease: A Preliminary Prospective Study. World Journal of Cardiovascular Diseases 06:02, pages 54-71.
Crossref
Sandeep K. Sharma, Erik Chorell & Pernilla Wittung-Stafshede. (2015) Insulin-degrading enzyme is activated by the C-terminus of ?-synuclein. Biochemical and Biophysical Research Communications 466:2, pages 192-195.
Crossref
Ekaterina G. Kochkina, Svetlana A. Plesneva, Dmitrii S. Vasilev, Igor A. Zhuravin, Anthony J. Turner & Natalia N. Nalivaeva. (2015) Effects of ageing and experimental diabetes on insulin-degrading enzyme?expression?in male rat tissues. Biogerontology 16:4, pages 473-484.
Crossref
Sandeep K. Sharma, Erik Chorell, Pär Steneberg, Emma Vernersson-Lindahl, Helena Edlund & Pernilla Wittung-Stafshede. (2015) Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner. Scientific Reports 5:1.
Crossref
Diego Sbardella, Grazia Raffaella Tundo, Francesca Sciandra, Manuela Bozzi, Magda Gioia, Chiara Ciaccio, Umberto Tarantino, Andrea Brancaccio, Massimo Coletta & Stefano Marini. (2015) Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution. PLOS ONE 10:7, pages e0132455.
Crossref
Clémentine Beuzelin, Irini Evnouchidou, Pascal Rigolet, Anne Cauvet-Burgevin, Pierre-Marie Girard, Delphine Dardalhon, Slobodan Culina, Abdelaziz Gdoura, Peter van Endert & Stefania Francesconi. (2013) Deletion of the Fission Yeast Homologue of Human Insulinase Reveals a TORC1-Dependent Pathway Mediating Resistance to Proteotoxic Stress. PLoS ONE 8:6, pages e67705.
Crossref
Matias B. de Tullio, Valeria Castelletto, Ian W. Hamley, Pamela V. Martino Adami, Laura Morelli & Eduardo M. Casta?o. (2013) Proteolytically Inactive Insulin-Degrading Enzyme Inhibits Amyloid Formation Yielding Non-Neurotoxic A? Peptide Aggregates. PLoS ONE 8:4, pages e59113.
Crossref
Grazia Raffaella Tundo, Diego Sbardella, Chiara Ciaccio, Antonio Bianculli, Augusto Orlandi, Maria Giovanna Desimio, Gaetano Arcuri, Massimiliano Coletta & Stefano Marini. (2013) Insulin-degrading Enzyme (IDE). Journal of Biological Chemistry 288:4, pages 2281-2289.
Crossref
María C. Leal & Laura Morelli. 2013. Handbook of Proteolytic Enzymes. Handbook of Proteolytic Enzymes 1415 1420 .
John E. Morley. (2010) Nutrition and the Brain. Clinics in Geriatric Medicine 26:1, pages 89-98.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.